Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

A total of 48 animal targets were reached with 100% usability and technical success and no visual acute intra-operative adverse events or complications This pivotal study, together with the...

Related Keywords

Israel ,Simon Sharon ,Michal Efraty ,Exchange Commission ,Microbot Medical Inc ,Nasdaq ,Robotic Surgical System ,Surgical System ,Investigational Device Exemption ,Microbot Medical ,Private Securities Litigation Reform Act ,Markets ,